Active, not recruiting
Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma
NCT07247383
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- 2ndAffiliated Hospital, School of Medicine, Zhejiang University, China Hangzhou, Zhejiang, China